New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2

Bioorg Chem. 2021 Sep:114:105117. doi: 10.1016/j.bioorg.2021.105117. Epub 2021 Jun 23.

Abstract

At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) and 6-fluoro-4-(2-(1-(4-methoxyphenyl)-1H-1,2,3-triazol-4-yl)ethoxy)-2-(trifluoromethyl)quinoline (12c) show high potency against SARS-CoV-2. The selectivity index (SI) of compounds 10g and 12c also indicates the significant efficacy compared to the reference drugs.

Keywords: Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / chemistry
  • COVID-19 Drug Treatment*
  • Click Chemistry
  • Humans
  • Molecular Docking Simulation
  • Quinolines / chemical synthesis*
  • Quinolines / chemistry
  • SARS-CoV-2
  • Triazoles / chemical synthesis*
  • Triazoles / chemistry

Substances

  • Antiviral Agents
  • Quinolines
  • Triazoles